Engineering Remotely Triggered Liposomes to Target Triple Negative Breast Cancer

Triple Negative Breast Cancer (TNBC) continues to present a challenge in the clinic, as there is still no approved targeted therapy. TNBC is the worst sub-type of breast cancer in terms of prognosis and exhibits a deficiency in estrogen, progesterone, and human epidermal growth factor 2 (HER2) recep...

Descripción completa

Detalles Bibliográficos
Autores principales: Sneider, Alexandra, Jadia, Rahul, Piel, Brandon, VanDyke, Derek, Tsiros, Christopher, Rai, Prakash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292187/
https://www.ncbi.nlm.nih.gov/pubmed/28174679
http://dx.doi.org/10.7150/oncm.17406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292187/
https://www.ncbi.nlm.nih.gov/pubmed/28174679
http://dx.doi.org/10.7150/oncm.17406

Ejemplares similares